by Danielle Bonadies | Jan 14, 2016 | News
We are excited to announce that our President and CEO Ellen Matloff has been invited to be a panelist at the FDA’s upcoming March 2 public workshop titled “Patient and Medical Professional Perspectives on the Return of Genetic Test Results.” She will speak on...
by Danielle Bonadies | Jul 27, 2015 | Genetic Journal
On July 10, 2015, the House of Representatives approved the 21st Century Cures Act (H.R. 6) with a vote of 344-77. This act will launch healthcare into the 21st century by “investing in science and medical innovation, incorporating the patient perspective, and...
by Danielle Bonadies | Feb 24, 2015 | Genetic Journal
A controversy has been brewing under the surface for several months in the genetic testing world. Namely, will BRCA carriers with ovarian cancer be forced to undergo BRCA testing a second time, at more than $4,000 a pop, in order to qualify for a new drug called...
